Tuberculosis in Spain: an opinion paper

Moreno Guillén, Santiago ; Rodríguez-Artalejo, Fernando ; Ruiz-Galiana, Julián ; Cantón, Rafael ; De Lucas Ramos, Pilar ; García-Botella, Alejandra ; García-Lledó, Alberto ; Hernández-Sampelayo, Teresa ; Gómez-Pavón, Javier ; González del Castillo, Juan ; Martín-Delgado, Mari Cruz ; Martín Sánchez, Francisco Javier ; Martínez-Sellés, Manuel ; Molero García, José María ; Santiago, Begoña ; Caminero, José Antonio ; Barros, Carlos ; García de Viedma, Darío ; Martín, Carlos (Universidad de Zaragoza) ; Bouza, Emilio

Resumen: This document is the result of the deliberations of the Committee on Emerging Pathogens and COVID-19 of the Illustrious Official College of Physicians of Madrid (ICOMEM) regarding the current situation of tuberculosis, particularly in Spain. We have reviewed aspects such as the evolution of its incidence, the populations currently most exposed and the health care circuits for the care of these patients in Spain. We have also discussed latent tuberculosis, the reality of extrapulmonary disease in the XXI century and the means available in daily practice for the diagnosis of both latent and active forms. The contribution of molecular biology, which has changed the perspective of this disease, was another topic of discussion. The paper tries to put into perspective both the classical drugs and their resistance figures and the availability and indications of the new ones. In addition, the reality of direct observation in the administration of antituberculosis drugs has been discussed. All this revolution is making it possible to shorten the treatment time for tuberculosis, a subject that has also been reviewed. If everything is done well, the risk of relapse of tuberculosis is small but it exists. On the other hand, many special situations have been discussed in this paper, such as tuberculosis in pediatric age and tuberculosis as a cause for concern in surgery and intensive care. The status of the BCG vaccine and its present indications as well as the future of new vaccines to achieve the old dream of eradicating this disease have been discussed. Finally, the ethical and medicolegal implications of this disease are not a minor issue and our situation in this regard has been reviewed.

Idioma: Inglés

DOI: 10.37201/req/115.2023

Año: 2023

Publicado en: Revista española de quimioterapia 36, 6 (2023), 562-583
ISSN: 0214-3429

Factor impacto SCIMAGO: 0.399 - Medicine (miscellaneous) (Q3) - Pharmacology (Q3) - Microbiology (medical) (Q3)

Tipo y forma: Article (Published version)

Área (Departamento): Área Microbiología (Dpto. Microb.Ped.Radio.Sal.Pú.)